Fresenius Kabi Oncology Ltd


BSE: 532545 | NSE: FKONCO | ISIN: INE575G01010 
Market Cap: [Rs.Cr.] 1,970 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Multinational

 Discuss this stock

Balance Sheet

(Rs. in Crores)
ParticularsMar-12Mar-11Mar-10Mar-09Mar-08Mar-07
SOURCES OF FUNDS :      
Share Capital 15.8215.8215.8215.8215.6715.67
Reserves Total 576.77525.52476.28396.05483.48319.22
Total Shareholders Funds592.59541.34492.10411.87499.15334.89
Secured Loans 11.1363.50117.46185.01194.85146.03
Unsecured Loans 136.19269.44151.6357.450.000.00
Total Debt147.32332.94269.09242.46194.85146.03
Total Liabilities739.91874.28761.19654.33694.00480.92
APPLICATION OF FUNDS :      
Gross Block 390.35321.01241.88230.16102.6495.98
Less : Accumulated Depreciation 85.4362.7146.7834.6528.3726.00
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 304.92258.30195.10195.5174.2769.98
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress138.2695.5757.772.81123.4292.26
Investments 0.03126.28129.40129.39183.37132.37
Current Assets, Loans & Advances      
Inventories 188.55207.22190.20132.5179.9459.85
Sundry Debtors 201.72176.59150.48102.1793.8857.23
Cash and Bank13.6418.5034.949.416.964.47
Loans and Advances 124.76142.92153.72202.19225.98133.11
Total Current Assets528.67545.23529.34446.28406.76254.66
Less : Current Liabilities and Provisions      
Current Liabilities 145.5586.2472.6946.5446.2853.78
Provisions 77.1459.7975.7664.6854.5010.08
Total Current Liabilities222.69146.03148.45111.22100.7863.86
Net Current Assets305.98399.20380.89335.06305.98190.80
Miscellaneous Expenses not written off 0.000.000.000.4614.202.64
Deferred Tax Assets8.626.088.467.771.080.54
Deferred Tax Liability23.2814.8110.4316.678.327.67
Net Deferred Tax-14.66-8.73-1.97-8.90-7.24-7.13
Total Assets734.53870.62761.19654.33694.00480.92
Contingent Liabilities17.9314.039.126.02116.64153.95

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Glaxosmit Pharma 20,681.62 31.24 10.29 18.86 34.3 45.2 0.00
Sanofi India 5,724.68 31.65 4.80 13.73 15.4 22.5 0.00
Pfizer 3,246.44 15.76 1.90 9.41 15.0 22.1 0.00
Abbott India 3,105.58 18.71 4.80 12.08 24.3 34.8 0.00
Fres.Kabi Onco. 1,969.59 23.06 2.93 22.38 3.5 5.4 0.42
Astrazeneca Phar 1,849.25 0.00 18.54 140.28 10.7 15.2 0.03
Wyeth 1,800.90 13.85 3.14 7.61 33.4 45.1 0.01
Novartis India 1,560.93 13.04 1.73 10.43 20.0 28.8 0.00
Merck 1,081.57 13.52 2.24 7.04 17.5 25.5 0.00
Fulford (India) 234.00 0.00 1.62 0.00 -3.4 -4.7 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Rakesh Bhargava , Chairman  

Dilip G Shah , Director  

Gerrit Steen , Director  

Michael Schonhofen , Director  


Company Head Office / Quarters:
B-310 Som Datt Chambers-I,
Bhikaji Cama Place,
New Delhi,
New Delhi-110066
Phone : 91-11-26105570
Fax : 91-11-26195965
E-mail : complianceofficer.india@fresenius-kabi.com
Web : http://www.fresenius-kabi-oncology.com
Registrars:
MCS Ltd
F-65 1st Floor
Okhla Industrial Are
Phase-I
New Delhi-110020

Fund Holding


Calendar

Jun-2013
M T W T F S S
17 18 19 20 21 22 23
IPO
listNo IPO today
Economic Events
list Adjusted Merchandise Trade Balance (Yen)
list Merchandise Trade Balance Total (Yen)
Results
list No result today